LIVER ENZYME ALTERATIONS ASSOCIATED WITH PLASMODIUM VIVAX AND FALCIPARUM MALARIA
Abstract
Malaria, caused by Plasmodium species, poses significant health challenges worldwide, particularly in endemic regions. This study investigates the alterations in liver enzyme levels associated with Plasmodium vivax and Plasmodium falciparum infections. We conducted a comparative analysis of liver function tests (LFTs) among confirmed malaria patients infected with either species, alongside a control group of healthy individuals. Enzyme levels, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin, were measured and analyzed. Our findings reveal a significant elevation in liver enzyme levels in patients infected with both P. vivax and P. falciparum compared to controls, with P. falciparum infections showing more pronounced derangements. The alterations in enzyme levels correlate with clinical severity and indicate potential hepatic involvement in malaria pathophysiology. These results underscore the importance of monitoring liver function in malaria patients and may contribute to developing targeted therapeutic strategies to mitigate hepatic complications. Further studies are warranted to elucidate the underlying mechanisms of liver enzyme derangement in malaria infections.
Keywords
Liver enzymes, Plasmodium vivax, Plasmodium falciparumHow to Cite
References
Arrow KJ, Panosian C, Gelband H. The parasite, the mosquito, and the disease. InSaving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance 2004. National Academies Press (US).
Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Defining and Defeating the Intolerable Burden of Malaria III: Progress and Perspectives: Supplement to Volume 77 (6) of American Journal of Tropical Medicine and Hygiene. 2007 Dec.
Ifeadike CO, Eleje GU, Ukibe NR, Oguejiofor CB. Influence of Malaria Parasitemia of Plasmodium Falciparum on the Prevalence and Severity of Premenstrual Syndrome. Journal of Clinical & Diagnostic Research. 2017 Nov 1;11(11).
Kotepui M, Piwkham D, PhunPhuech B, Phiwklam N, Chupeerach C, Duangmano S. Effects of malaria parasite density on blood cell parameters. PloS one. 2015 Mar 25;10(3):e0121057.
Saravu K, Docherla M, Vasudev A, ShastryB. Thrombocytopenia in vivax and falciparum malaria: an observational study of 131 patients in Karnataka, India. Annals of Tropical Medicine & Parasitology. 2011 Dec 1;105(8):593-8.
Baron S, Wakelin D. Helminths: pathogenesis and defenses. Medical Microbiology. 4th ed. Galveston (TX): University of Texas. 1996.
Jairajpuri ZS, Rana S, Hassan MJ, Nabi F, Jetley S. An analysis of hematological parameters as a diagnostic test for malaria in patients with acute febrile illness: an institutional experience. Oman medical journal. 2014 Jan;29(1):12.
Anand AC, Puri P. Jaundice in malaria. Journal of gastroenterology and hepatology. 2005 Sep;20(9):1322-32.
World Health Organization. Management of severe malaria: a practical handbook. World Health Organization; 2000.
World Health Organization. Methods for surveillance of antimalarial drug efficacy;2009.
Phillips RS. Current status of malaria and potential for control. Clinical microbiology reviews. 2001 Jan 1;14(1):208-26.
License
Copyright (c) 2024 Dr Obaim Noman
This work is licensed under a Creative Commons Attribution 4.0 International License.